Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

2013: The year’s biggest Medical Device stories

Canada's pharmaceutical company Valeant Pharmaceuticals entered into a definitive agreement to acquire Bausch + Lomb Holdings for $8.7bn, while Abbott obtained US Food and Drug Administration (FDA) approval for its first-in-class, catheter-based MitraClip therapy. Medicaldevice-network.com wraps-up the key headlines from 2013.

Go Top